AIM IP specialist Tekcapital to sell or float all four portfolio companies 'within 2 years'. Watch the full video here

Less Ads, More Data, More Tools Register for FREE

UPDATE 1-White House slams WHO over criticism of push for COVID-19 vaccine

Tue, 1st Sep 2020 21:16

(Adds background)

WASHINGTON, Sept 1 (Reuters) - The White House on Tuesday
pushed back on concerns expressed by the World Health
Organization after a U.S. health official said a coronavirus
vaccine might be approved without completing full trials.

"The United States will continue to engage our international
partners to ensure we defeat this virus, but we will not be
constrained by multilateral organizations influenced by the
corrupt World Health Organization and China," White House
spokesman Judd Deere said in a statement.

"This President will spare no expense to ensure that any new
vaccine maintains our own FDA's gold standard for safety and
efficacy, is thoroughly tested, and saves lives," he said.

U.S. Food and Drug Administration Commissioner Stephen Hahn
told the Financial Times in an interview published on Sunday
that the FDA was prepared to authorize a coronavirus vaccine
before late-stage Phase Three clinical trials were complete, as
long as officials are convinced that the benefits outweigh the
risks.

On Monday, World Health Organization officials said moving
too quickly to make a vaccine widely available could pose risks.

"If you move too quickly to vaccinate ... millions of
people, you may miss certain adverse effects," said Mike Ryan,
the head of WHO's emergencies program.

WHO chief scientist Soumya Swaminathan said the FDA's
approach was "not something that you do very lightly." She said
WHO's preferred approach would be to have a full set of data
which could be used for the pre-qualification of vaccines.

President Donald Trump has been critical of the WHO's
handling of the coronavirus pandemic, accusing it of being too
focused on China and issuing bad advice. In May, Trump announced
the United States was cutting ties to the organization.

Phase Three trials, in which randomized patients are treated
with a drug or a placebo without participants or doctors knowing
which group they were in, are considered the gold standard for
clinical trials.

(Reporting by Jeff Mason; Writing by Eric Beech; Editing by
Sandra Maler and Leslie Adler)

More News

EU's Breton: EU did not renew Astrazeneca COVID-19 vaccine order for after June

PARIS, May 9 (Reuters) - European Internal Market Commissioner Thierry Breton said on Sunday the European Commission did not renew its order for AstraZeneca vaccines against COVID-19 for after June.The European Commission last month launched legal...

Today 11:30

ECB's Rehn calls for change to ECB’s inflation target in line with Fed approach- FT

May 9 (Reuters) - The European Central Bank should follow the U.S. Federal Reserve by accepting an overshooting of its inflation target to make up for many years of sluggish price growth, Finnish central bank chief Olli Rehn told the Financial Ti...

Today 11:19

UK PM calls summit as Sturgeon says 2nd referendum is will of Scotland

UK PM calls summit as Sturgeon says 2nd referendum is will of Scotland

Today 09:49

Soccer-Man City made to wait for title by Chelsea, Liverpool boost top-four hopes

By Martyn HermanLONDON, May 8 (Reuters) - Hundreds of Manchester City fans gathered outside the Etihand Stadium for a Premier League title celebration that proved premature as Chelsea ruined the script with a last-minute 2-1 victory on Saturday.City ...

8 May 21 23:49

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.